CVS Group’s (CVSG) Buy Rating Reiterated at Berenberg Bank

Berenberg Bank reaffirmed their buy rating on shares of CVS Group (LON:CVSG) in a research report report published on Thursday, Marketbeat.com reports. Berenberg Bank currently has a GBX 2,370 ($30.65) price target on the stock.

CVS Group Price Performance

CVS Group stock opened at GBX 1,106 ($14.30) on Thursday. The company has a debt-to-equity ratio of 100.75, a quick ratio of 0.90 and a current ratio of 1.15. The company has a market capitalization of £792.67 million, a price-to-earnings ratio of 2,257.14, a price-to-earnings-growth ratio of 1.77 and a beta of 0.95. The company’s 50 day simple moving average is GBX 1,069.74 and its 200-day simple moving average is GBX 1,211.92. CVS Group has a 1 year low of GBX 902.41 ($11.67) and a 1 year high of GBX 2,225 ($28.78).

Insider Activity

In other news, insider Richard Gray bought 1,600 shares of the company’s stock in a transaction on Wednesday, July 10th. The stock was bought at an average cost of GBX 1,019 ($13.18) per share, with a total value of £16,304 ($21,086.39). In other news, insider Deborah Kemp purchased 2,440 shares of the firm’s stock in a transaction that occurred on Wednesday, June 26th. The stock was bought at an average price of GBX 1,024 ($13.24) per share, for a total transaction of £24,985.60 ($32,314.54). Also, insider Richard Gray acquired 1,600 shares of the company’s stock in a transaction dated Wednesday, July 10th. The stock was acquired at an average price of GBX 1,019 ($13.18) per share, for a total transaction of £16,304 ($21,086.39). Insiders own 1.46% of the company’s stock.

About CVS Group

CVS Group plc, together with its subsidiaries, engages in veterinary, pet crematoria, online pharmacy, and retail businesses. The company operates through four segments: Veterinary Practices, Laboratories, Crematoria, and Online Retail Business. It operates in animal veterinary practices and complementary veterinary diagnostic businesses.